CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) to Webcast Live at Life Sciences Investor Forum

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), based in Vancouver, Canada, focused on manufacturing pharmaceutical-grade cannabinoids via synthetic biology, today announced that its president and CEO, Trevor Peters, will present live at LifeSciencesInvestorForum.com at 2:30 p.m. ET on September 17, 2020. Interested parties may register for and access the presentation at http://cnw.fm/aTrB8. Investors are invited to ask the company real-time questions at the live, interactive online event. An archived webcast will be available after the event for those unable to attend live on the day of the conference.

To view the full press release, visit http://cnw.fm/wKZzE

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Vancouver, Canada, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CanadianCannabisWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Receipt of Statement of Claim Relating to PharmHouse JV

Canopy Rivers (TSX: RIV) (OTC: CNPOF), today announced its receipt of a statement of claim filed by 2615975 Ontario Inc., the company’s joint venture (“JV”) partner in PharmHouse Inc., concerning certain disputes relating to PharmHouse. According to the update, the claim makes a number of allegations against the company, Canopy Growth Corporation and TerrAscend Corp. and TerrAscend Canada Inc. (together, “TerrAscend”), including claims relating to bad faith, fraud, civil conspiracy, breach of the duty of honesty and good faith in contractual relations and breach of fiduciary duty, and claims relating to PharmHouse’s offtake agreements with Canopy Growth and TerrAscend. The company considers the claim as it relates to the actions of Canopy Rivers to be completely without merit and intends to vigorously defend its position at the appropriate time and in the appropriate forum.

To view the full press release, visit http://cnw.fm/lc7UW

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. Canopy Rivers believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging its industry insights, in-house expertise, and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders with exposure to specialized and disruptive cannabis companies. The company’s mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, Canopy Rivers is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CanadianCannabisWire is part of the InvestorBrandNetwork.

420 with CNW – Illinois Social Equity Applicants Want Marijuana License Lottery Delayed

It is widely known that the decades’ long war on drugs wreaked havoc on certain communities. In fact, when advocates started pushing for the decriminalization of marijuana way back, one of their biggest objectives was to help communities that had been adversely affected by the war on drugs. For most states that legalized cannabis, that included granting more cannabis dispensary licenses to minorities that qualified for social equity as well as expunging the records of those with marijuana-related charges.

Illinois’ legal cannabis program was no different. The state’s recreational cannabis law required that people with low-level marijuana convictions have their records cleared and minorities that had been disproportionately affected by the war on drugs were to be given special consideration in regards to cannabis dispensary licenses. However, months after Illinois legalized recreational cannabis, some social equity applicants say the state is falling short of its objective to repair the systemic harm caused by the war on drugs.

“The spirit of the law is to repair those harms and create true equity within that demographic,” says Belica Royster, a social equity applicant. She and other social equity applicants argue that the state is not awarding enough marijuana dispensary licenses to minority owners. According to a group called the Social Equity Empowerment Network, the process to award 75 new cannabis dispensary licenses has not been equitable. The denied social equity applicants are asking Governor JB Pritzker for transparency in how the social equity status is awarded.

“We just want the playing field to be fair, that’s all we wanted. And based on how the outcome was, even part of the process, it was not, in fact, fair,” says Indrani Peyton, another social equity applicant. She was part of a group that applied for social equity status but failed to get a license. In total, more than 700 groups submitted 4,000 applications and according to the state, only 21 will advance to the next stage.

“The facts show that of the 21 applicants only 12 are owned and controlled by people of color. How is that maximizing social equity with these numbers?” says Royster. She states that most of the winners are tied to big marijuana companies, two with links to restauranteur Phil Stefani and former Chicago Police Supt. Terry Hillard. Applicants who are majority owned by a person living in an area affected by the war on drugs, someone with a marijuana-related arrest or a company that can employ 10 people who meet that criteria have a higher chance of gaining social equity status.

“All that chalks up to be is an employer, and to me, that does not balance the scales of justice,’ Peyton says. Some social equity applicants who fell out of the race have filed federal lawsuits against Gov. Pritzker’s administration, hoping to delay the lottery until there is more transparency.

Industry watchers say cannabis entities like Pure Extract Technologies Inc. would wish to see the complaints of the social equity applicants addressed so that what was envisioned when passing the legalization law is put into practice.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Federal Report Reveals Few Banks Worked with Cannabis Businesses Amidst the Pandemic

The latest data from the federal government shows that in the last fiscal quarter, few financial institutions are servicing firms in the cannabis industry. In fact, the number is said to have declined.

Last week, a report released by the Financial Crimes Enforcement Network showed that 695 credit unions and banks were working with legal marijuana businesses at June’s end. However, in the previous quarter, the number was 710, showing a clear decline.

What then, is behind the apparent decline?

COVID-19 is one of the culprits. The coronavirus pandemic has affected many economies globally, with most businesses either going bankrupt or closing down. It is no wonder that some cannabis firms may have closed down as well during this period, given that most government restrictions require only essential businesses and services to be in operation during the pandemic period.

However, most states which have legalized cannabis are allowing marijuana firms to operate as essential services during this pandemic period, with states such as Illinois recording growth in cannabis sales in the past few months.

Another possible reason for the decrease in support from financial institutions could be banks being understaffed. Understaffing causes delays in filing suspicious activity reports (“SAR”) for cannabis businesses. All credit unions and banks that provide financial services to cannabis businesses are required, by law, to file and submit suspicious activity reports.

Filers that exceed the 90-day SAR filing requirement may explain the short-term decline in the number of financial institutions that are offering services to marijuana businesses. This is because, after the 90-day period has elapsed, the depository institution is deemed to not be providing financial services.

The decline might also be a result of Congress calling for cannabis law reform.

On a lighter note though, the Marijuana Opportunity, Reinvestment and Expungement (“MORE”) Act is scheduled to be introduced to the floor later in September. It seeks to remove cannabis from the Controlled Substances Act, which would resolve any uncertainty revolving around financial institutions working with cannabis businesses in the banking sector.

This would open up more avenues for financial institutions to provide services to marijuana firms in the future.

Furthermore, earlier in June, the National Credit Union Administration released a memo that explained the issues that are identified with banking institutions offering their services to cannabis businesses and explained that offering services is legal, as marijuana has been legalized in most states.

It would be interesting to get the perspective of industry players like Pac Roots Cannabis Corp. (CSE: PACR) regarding what could be behind the reduced collaboration between banks and cannabis companies.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Savvy Companies Eye Promising Potential in Multi-Billion-Dollar Industry

CannabisNewsWire Editorial Coverage: A recent Data Bridge Market Research report notes that the once-hot cannabis industry looks to be heating up again — in a big way. The report includes predictions that the global legal marijuana market will total more than $90 billion by 2027. Smart companies are jostling for a strong position in this explosive space, looking to leverage their expertise to capitalize on opportunities the multi-billion-dollar sector provides. Recognizing key challenges in the industry, including availability of often subpar quality of available product along with the high cost of development and land acquisition, Pac Roots Cannabis Corp. (CSE: PACR) (PACR Profile) is focusing on its state-of-the-art genetics to ensure production of premium-quality products. In addition, the company is relying on science and key strategic partnerships to eliminate quality and cost barriers to success. Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) has received regulatory approval for its acquisition of one of 10 vertically integrated licenses in New York while Tilray Inc. (NASDAQ: TLRY) has received complete GMP certification at its EU campus. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has almost completed the first phase of a business transformation focused on setting up the company for success in this burgeoning space. And in the medical-use sector, Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is pursuing a significant unmet opportunity for a targeted IBS pain treatment using olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2 (CB₂).

Absolute access to one of Canada’s largest live, genetic cannabis library provides PACR with more than 350 lab-tested, field-tested cultivars.
Superior flowers are key to producing superior cannabis products.
Pac Roots chooses best outdoor growing climates in Canada for its growing cultivation operations.

Click here to view the custom infographic of the Pac Roots Cannabis Corp. (CSE: PACR) editorial.

Delivering the Best

While it may seem obvious, the availability of high-quality flowers is essential to the process of producing high-quality cannabis products. Yet as demand for cannabis products has increased and more companies have entered the flourishing space, the quality of raw cannabis product may actually be slipping as companies focus more on market share than quality.

Pac Roots Cannabis Corp. (CSE: PACR) is committed to delivering the finest cannabis genetics to its customers, preserving the superiority of its carefully cultivated elite strains while also working to introduce unmatched new strains. While some companies may work to be the largest cannabis grower, Pac Roots believes that product quality is paramount. With demand for premium products at an all-time high, Pac Roots is dedicated to becoming a leader in the premium-cannabis space.

The company achieves this objective in part through its strategic licensing agreement with Phenome One Corp, which gives Pac Roots complete access to one of Canada’s largest live, genetic cannabis library with both field- and lab-tested, selectively bred cultivars. Pac Roots utilizes the cultivars in the Phenome One library to grow, breed and clone its own distinctive brands. Through vigilant breeding and cultivation, Pac Roots offers everything from CBD-dominant plants with rare terpene profiles and soaring 30%-plus THC giants to West Coast outdoor, botrytis-resistant plants.

Pac Roots and Phenome One are developing exclusive strains with several beneficial characteristics. The impressive catalog consists of more than 350 tested cultivars; approximately 50 are in the super-elite category. The aim for the partnership is to offer the highest-quality cultivars that have been proven and tested under variable commercial conditions to provide the greatest resilience. The two companies share a dedication to delivering rich THC and CBD cultivars with unique terpene profiles while continuing to attain industry-leading GPW yield.

Key to Quality Cannabis

Superior genetics isn’t the only key to cultivating quality cannabis. Optimized farming systems are crucial in the pursuit of quality product. Pac Roots works closely with carefully selected partners to improve cultivation through proprietary methods, including the following fundamental components:

Nutrients are custom formulated from raw salts for specific cultivars.
Systematic planting of young, hardy cultivars, measuring up to 18 inches, which provides maximum opportunity for growth and resilience.
Row compaction and mowing for weed control, enabling a selected harvest
Complex irrigation systems with direct-nutrient and spring-water delivery to each plant site.

In addition to observing tested and refined cultivation methods, Pac Roots carefully selected its cultivation sites, focuses its operations on the finest outdoor growing climates in Canada, including the South Okanagan Valley and the Fraser Valley Regional District.

Golden Mile Cultivation

Known as the Golden Mile and now referred to as the Napa Valley of the North, the South Okanagan Valley in British Columbia is the location of Rock Creek Farms, a 100-acre, premium-hemp, joint venture that Pac Roots started in May 2020 after receiving its hemp cultivation license from Health Canada.

Planting began in June when approximately 130,000 premium-hemp CBD seedlings, which had been sown earlier in greenhouses to ensure optimum growth and reduce environmental impact, were systematically planted across two 50-acre parcels. With harvesting projected to begin in October, the hemp plantation crop is expected to be between 500,000 and 700,00 pounds of biomass; 100% of that yield is already under contract with a processor at fair market value.

“It has been a busy for months since listing on the CSE in early May 2020,” said Pac Roots CEO Patrick Elliott. “We are proud to have a healthy crop and remain bullish on delivering a premium, high-yielding product to our customer. In early 2020, we had a goal of becoming a revenue generator in 2020 as market appetite was evolving towards a cash flow scenario and realizing on projected forecasts as paramount to survival in this industry. We are privileged to be involved with our strategic partners at Rock Creeks Farms, Phenome One and Speakeasy Cannabis Club as a production scenario in our first year of operation would not have been possible without the generous leasing of land, equipment, licenses, infrastructure, genetics, operations team, management and expertise to round off the joint venture.”

Fraser Valley Production

In addition, the company is slated to soon complete a share purchase agreement of 250 acres of prestigious land in the Fraser Valley Regional District (FVRD) of British Columbia. The agreement, made with 1088070 BC. Ltd. outlines Pac Roots’ plans to acquire all of the issued and outstanding shares of 1088, which owned nine parcels of pristine property in FVRD, one of the most productive and intensively farmed areas in Canada. The area offers the finest soil, a favorable climate, ample water and a local market of an estimated 2.5 million people. Agriculture in this region yields an annual economic value of more than $3 billion.

“The addition of such a substantial package of land to our portfolio is a major step for Pac Roots,” said Elliott. “We are pleased to have the opportunity to add significant acreage with an acquisitional cost base of $9,600 per acre. This land has no zoning restrictions and is not situated within the Agricultural land reserve, which provides for infinite development possibilities.”

The acquisition of the 250 FVRD acres combined with the 100-acre hemp joint venture in Rock Creek, along with the company’s plans for an indoor cultivation facility in Lake Country, British Columbia, demonstrates a long pipeline of development projects for Pac Roots. Through these recent achievements, the growing company is confirming its ability to optimize cultivation with seasoned expertise. Its commitment to maximizing yield while lowering production costs seems evident throughout Pac Roots’ strategic growth plan.

With demand for superior cannabis products only expected to increase as large-scale growers appear incapable of delivering a premium-grade flower, Pac Roots looks to have firmly established its focus on offering the best crops available and developing the future of genetics. “Preserving the excellence of our elite strains while introducing the highest quality of new strains to the public is our passion,” the company’s website declares, and its recent activity in the cannabis market looks to support that mission.

Becoming Cannabis Players

While Pac Roots is distinctive in its approach and commitment to quality, it isn’t the only company vying for market share in the flourishing cannabis sector.

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) announced that it has received regulatory approval for its acquisition of 100% of the membership interests of Gloucester Street Capital, the parent entity of Valley Agriceuticals LLC, via a merger between Gloucester and an indirect subsidiary of Cresco Labs. Valley Agriceuticals holds one of the 10 vertically integrated cannabis business licenses granted in the State of New York by the New York State Department of Health. Each license gives the operator the right to operate one cultivation facility and four dispensaries in New York. The acquisition is expected to close by the end of August.

Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) recently released an update on its business operations, including the announcement of a new CEO, Miguel Martin. “Over the last six months, Aurora has focused on building the infrastructure and capabilities necessary for a successful and diversified business,” said Aurora executive chairman and interim CEO Michael Singer. “The first phase of our business transformation, which is now substantially complete, included the rationalization of our cost structure, reduced capital spending, and a more prudent and targeted approach to capital deployment. As a result, we now have a far more efficient asset base and infrastructure to supply our key global markets. I am delighted to now be transitioning the CEO responsibilities to Miguel, and I am confident that Aurora is in a strong position to succeed under Miguel’s leadership.”

Tilray Inc.’s (NASDAQ: TLRY) wholly owned subsidiary Tilray Portugal Unipessoal Lda. has received a Good Manufacturing Practice (GMP) certification in accordance with European Union standards, for its manufacturing facility in Cantanhede, Portugal. The certification expands the company’s international export capacity to serve authorized medical cannabis markets and provides authorization to complete medical cannabis extraction on-site as well as produce bulk extracts for the manufacture of medical cannabis oil as a finished product. The certification signals another milestone for Tilray’s EU campus, which serves as the company’s international medical cannabis hub.

Another player in the medical space is Arena Pharmaceuticals Inc. (NASDAQ: ARNA). The company has recognized a significant unmet opportunity for a targeted IBS pain treatment and is involved in a Phase 2, placebo-controlled, parallel-group study to evaluate the safety, tolerability, and efficacy of olorinab in patients with irritable bowel syndrome who are experiencing abdominal pain.

In an industry anticipated to top $90 billion by 2027, strategic steps taken by companies operating in the cannabis space appear to reinforce the sector’s promising future. Companies that focus on high-quality products through genetics while controlling costs could reap outsized market rewards as the sector continues to grow and mature.

For more information about Pac Roots, please visit Pac Roots Cannabis Corp. (CSE: PACR).

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Congressional Bill Seeks to Allow CBD and Other Hemp Ingredients to Be Sold as Supplements

Two congressmen have introduced a bill that would allow CBD and other hemp extracts to be marketed and sold as dietary supplements. Sponsored by Reps. Kurt Schrader and Morgan Griffith, the bipartisan legislation would make it clear that Congress intends on making federally regulated CBD and other hemp products available to American consumers. Although industrial hemp and its extracts were legalized in December 2018, the nascent industry lacks a national regulatory framework. The new bill seeks to clear the legal confusion around CBD and allow licensed retailers to sell CBD products.

“Hemp was historically an important crop for Virginia farmers, and dietary supplements made from it do not possess dangerous addictive qualities. Nevertheless, the current state of regulation creates confusion about its legal uses,” said Rep. Griffith in a press release. “I joined this bipartisan bill to provide certainty for hemp farmers that their crop may find legal uses.”

Titled the “Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020,” the bill would mandate that “cannabis derived from hemp shall be lawful under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement. Under the bill, hemp-derived CBD would still have to comply with federal requirements on packaging and labeling as well as FDA rules regarding new dietary ingredients. According to industry advocates who pushed for a clear federal path for hemp-derived CBD, the measure would boost consumer confidence in CBD products and help businesses that poured money into hemp production when it was legalized.

The U.S. Hemp Roundtable said in a press release that thousands of farmers and small businesses invested in what was widely seen as a CBD boom. “However, public announcements by the FDA questioning the legality of ingestible hemp-derived products have hindered the progress of the industry and put at risk the livelihoods of many hemp farmers. Not only did the lack of clarity spell economic disaster, but it also resulted in a lack of regulations around quality, leaving consumers unprotected.”

The legislation is part of an ongoing effort by the federal government to regulate the nascent hemp and hemp extract industry which has been termed by some as the ‘wild west’. Last year, a bipartisan group of 26 House members sent a letter to the Food and Drug Administration (“FDA”) urging the agency to provide a path for CBD products to be legally marketed and sold. The lawmakers said that the FDA’s “current significant regulatory posture on CBD has created significant regulatory and legal uncertainty for participants in this quickly evolving industry.”

If this bill became law, analysts are convinced that the entire cannabis sector, including Sugarmade, Inc. (OTCQB: SGMD), would regard it as one of the best pieces of legislation that has been passed in recent years.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Research Finds Cannabis Use Has Grown Among Baby Boomers

A recent study that was published in the Annals of Internal Medicine last Monday, shows that the use of cannabis among people aged between 56 and 74, is on the rise in America, with men in the lead. The baby boomer generation which makes up people aged between 56 and 74, refers to people who were born between the year 1946 and 1964. They make up about 20% of the world’s population, mostly in developed nations.

The study’s co-author, Bill Jesdale, suggests that the attitudes toward marijuana in the country seem to be changing. Bill Jesdale, who also works at the University of Massachusetts Medical School as an assistant professor of Population and Quantitative Health, also stated that the findings showed an increase in the use of cannabis in older people. This applies to states where cannabis has not been legalized for recreational use as well as in states where it’s been legalized.

The data used in the study was collected for a 3-year period (2016-2018) and focused on the use of marijuana in 171,507 grown-ups aged 55 and above, from 2 territories and 19 states.

Men aged 60 to 64 recorded the highest cannabis use rates, with 12.6% admitting to having used cannabis in the last 30 days in the year 2018, which is an increase from the 2016 rate, which was 3.7%. Over the same period of time, cannabis use is said to have almost doubled, to 8.2% in 2018 from 4.3% in 2016, in men aged 65 to 69 and in men aged 70 to 74, a rise to 6% from 3.2%. In women, a lesser change was recorded.

Despite the study itself not offering any explanations that would demonstrate why exactly more and more boomers are using marijuana, Jesdale as well as his colleagues suggest possible explanations, such as,

Lowered inhibitions against use
Increased availability of marijuana
Lower stigma linked to cannabis use
Numerous medical benefits coming to light

The researchers also added that other studies discovered that older people have been using marijuana to help with anxiety, pain as well as sleep problems.

In spite of this though, experts warn that marijuana use in people who are older might grow the risk of drug interactions, especially if combined with some types of medication. Researchers suggest that how marijuana affects older grown-ups may not be similar to what younger individuals experience when they use marijuana.

For instance, a review that was published earlier this year revealed that a combination of various heart medications and cannabis put consumers at risk. Dizziness, confusion, falls as well as other accidents have also been recorded.

Industry watchers say that the fact that older people are waking up to the benefits of marijuana isn’t surprising the sector players like The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) who have always known about those nearly limitless benefits.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Adds New Distributor, Builds Momentum in Eco-Friendly Bottle Sector

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that it has added Valu Merchandisers Company (“VMC”) as a distributor covering Midwest and Southern states. In addition, the company announced that H-E-B will now carry Alkaline88(R) aluminum bottles in 288 stores across Texas and receipt of strong initial orders from KeHE and UNFI, which recently agreed to carry the Alkaline88 eco-friendly aluminum bottles. “It is exciting to see momentum build around our eco-friendly and truly sustainable aluminum bottles,” said WTER president and CEO Ricky Wright in the press release. “Since its launch earlier this year, we have seen growing consumer demand for the product and see it as a perfect fit in the all-natural and organic channel. With UNFI and KeHE already carrying this line, the addition of VMC as a channel partner further strengthens our position in this category. VMC is one of the largest providers to more than 3,800 independently owned supermarkets, with a concentrated footprint in the Midwest and Southern markets. Our recent partnerships now give us reach into over 60,000 regional, national and independently owned grocery stores for our eco-friendly aluminum bottles. This positions us firmly to capture growth in the reusable water bottle market segment, which is expected to reach $1.5 billion by 2025.”

To view the full press release, visit http://cnw.fm/oO96j

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies. To learn more about the company, visit www.A88CBD.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CanadianCannabisWire is part of the InvestorBrandNetwork.

420 with CNW – Bags of Marijuana Rain on Tel Aviv Streets

Residents of Tel Aviv were treated to a rare sight last Thursday after drones dropped hundreds of small bags of cannabis over the infamous Rabin Square. Dozens of people watched curiously as the small packets of cannabis floated down to the ground, with some even running into the streets to collect as many bags as they could carry. The illegal consignment of marijuana was delivered by a group called Green Drone, which announced to its followers on Telegram that it was the start of an ongoing “rain of cannabis.”

“It’s time my dear brothers. Is it a bird? Is it a plane? No, it’s the green drone, handing out cannabis from the sky. Enjoy my beloved brothers, this is your pilot brother, making sure we all get some free love,” the group wrote before the drop. Green Drone, whose slogan is ‘free love,’ advocates for the legalization of cannabis in Israel. “We’re launching the ‘rain of cannabis’ project, which will include a weekly delivery to different parts of the country of 2 pounds of cannabis divided into free 2 grams bags.”

The group also addressed the imminent threat of a government-imposed lockdown to curb the spread of the coronavirus pandemic stating that the situation “requires thinking outside the box and coming up with new ways to getting cannabis to consumers.” This led to the birth of the “rain of cannabis” project.

Shortly after the incident, the police announced that they had arrested two suspects in their 30s who allegedly operated the drone that flew over Rabin parks and dropped hundreds of bags of cannabis. The distribution of a substance suspected to be dangerous is illegal, and the suspects will be interrogated and dealt with accordingly, the police say. Despite that, Green Drone has stated that it will continue dropping 2 pounds of marijuana in small bags every week over different parts of the country.

Cannabis remains illegal except for limited medical circumstances in Israel. Earlier this year, the legislature voted to advance two bills that would legalize cannabis for preliminary reading, one introduced by Likud MK Sharren Haskel and another introduced by Blue and White MK Ram Shefa. According to Haskel, who was born in Toronto where cannabis is legal, 30% of Israeli adults use cannabis, and legalizing it will save them money and manpower spent by police ticketing the tens of thousands of people who use cannabis.

The bills are expected to be combined in committee and sent back through the legislative process as a government-sponsored bill. It will then have to pass through the committee and the plenum three more times each to become law.

It would be interesting to hear what North American cannabis companies like Pure Extract Technologies Inc. think about the brand of activism adopted by Green Drone.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Survey Finds 81% Support for Marijuana Legalization in Mississippi

As the November 3 ballot approaches, drug reform advocates in Mississippi will be happy to know that a majority of the state’s potential voters support the legalization of medical marijuana. After conducting telephone surveys with 600 Mississippians likely to vote in the November 2020 general election, California-based research company FM3 Research found out that 81% of them supported medical marijuana.

“In principle, four in five (81%) Mississippi voters support doctors being able to recommend medical marijuana to patients with medical conditions and serious illnesses, and more than two thirds (68%) do so strongly,” writes the firm in a key findings memo. The state has two legalization measures on the ballot, Initiative 65, which was placed on the ballot with the signatures of 228,000 Mississippians, and Alternative 65A which was placed on the ballot by the state legislature.

According to FM3 Research, Mississippians strongly favor permitting access to medical marijuana through Initiative 65, with 52% of the respondents supporting Initiative 65 and 23% supporting Alternative 65A. Ballotpedia states that “Initiative 65 supports approving the medical marijuana amendment as provided by Initiative 65, which would allow medical marijuana treatment for more than 20 specified qualifying conditions, allow individuals to possess up to 2.5 ounces of marijuana at one time and tax marijuana sales on the current state sales tax of 7%.”

On the other hand, “Alternative 65A supports approving the legislature’s alternative medical marijuana amendment, which would restrict smoking marijuana to terminally ill patients; require pharmaceutical-grade marijuana products and treatment oversight by licensed physicians, nurses, and pharmacies, and leave tax rates, possession limits, and certain other details to be set by the legislature.”

“Without Initiative 65, people are having to use pharmaceutical drugs to treat their pain and suffering. Are narcotics better? I don’t think so. This would be a whole lot better because there’s no side effects and there’s no addiction,” says Barbara Allen, a member of Medical Marijuana 2020’s steering committee. Medical Marijuana 2020 is behind the push for legalization, and the organization says that ignoring the harmful side effects of currently prescribed and legal medications cannot continue.

However, not everyone is happy about it. Jackson County Sherriff Mike Ezell says that it will create more work for law enforcement. “The sheriff’s office now answers between 26 and 2,800 calls a month. You add marijuana to this mix and, you know the teenagers and young adults, they’re gonna get it. It’s just like we talked about earlier with the brownies and the gummies and all the things they bring back from Colorado. We’ve made a number of arrests since I’ve been in office.”

“In summary, Initiative 65 stands a strong chance of passage in November 2020 in Mississippi. There is substantial support for medical marijuana in principle, and voters clearly distinguish between Initiative 65 and Alternative 65A,” the study concluded.

Industry watchers say entities like Pac Roots Cannabis Corp. (CSE: PACR) hope that the voters get accurate information about the two initiatives and vote based on concrete data in November.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.